1Second Dept. of Medicine, Okayama University Medical School.
Low dose behenoyl ara-C (LD-BHAC) showed a 75% response rate in hypoplastic leukemia (HL), while K-18 achieved complete remission in 2 of 6 patients. Both treatments show promise for HL and related conditions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: